165 related articles for article (PubMed ID: 34078558)
1. Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation.
Gochi F; Chen-Yoshikawa TF; Kayawake H; Ohsumi A; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Hamaji M; Yurugi K; Hishida R; Date H
J Heart Lung Transplant; 2021 Jul; 40(7):607-613. PubMed ID: 34078558
[TBL] [Abstract][Full Text] [Related]
2. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
3. Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients†.
Date H; Sato M; Aoyama A; Yamada T; Mizota T; Kinoshita H; Handa T; Tanizawa K; Chin K; Minakata K; Chen F
Eur J Cardiothorac Surg; 2015 Jun; 47(6):967-72; discussion 972-3. PubMed ID: 25228745
[TBL] [Abstract][Full Text] [Related]
4. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
[TBL] [Abstract][Full Text] [Related]
6. Native lung complications after living-donor lobar lung transplantation.
Mineura K; Chen-Yoshikawa TF; Tanaka S; Yamada Y; Yutaka Y; Nakajima D; Ohsumi A; Hamaji M; Menju T; Date H
J Heart Lung Transplant; 2021 May; 40(5):343-350. PubMed ID: 33602629
[TBL] [Abstract][Full Text] [Related]
7. Airway complications have a greater impact on the outcomes of living-donor lobar lung transplantation recipients than cadaveric lung transplantation recipients.
Sugimoto S; Yamane M; Otani S; Kurosaki T; Okahara S; Hikasa Y; Toyooka S; Kobayashi M; Oto T
Surg Today; 2018 Sep; 48(9):848-855. PubMed ID: 29680912
[TBL] [Abstract][Full Text] [Related]
8. Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation.
Islam AK; Sinha N; DeVos JM; Kaleekal TS; Jyothula SS; Teeter LD; Nguyen DTM; Eagar TN; Moore LW; Puppala M; Wong STC; Knight RJ; Frost AE; Graviss EA; Osama Gaber A
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658512
[TBL] [Abstract][Full Text] [Related]
9. Impact of Spousal Donation on Postoperative Outcomes of Living-donor Lobar Lung Transplantation.
Kayawake H; Tanaka S; Yutaka Y; Yamada Y; Ohsumi A; Hamaji M; Nakajima D; Yurugi K; Hishida R; Date H
Transplantation; 2023 Aug; 107(8):1786-1794. PubMed ID: 36895091
[TBL] [Abstract][Full Text] [Related]
10. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
11. Postoperative outcomes of lung transplant recipients with preformed donor-specific antibodies.
Kayawake H; Chen-Yoshikawa TF; Gochi F; Tanaka S; Yurugi K; Hishida R; Yutaka Y; Yamada Y; Ohsumi A; Hamaji M; Nakajima D; Date H
Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):616-624. PubMed ID: 33351064
[TBL] [Abstract][Full Text] [Related]
12. Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension.
Kayawake H; Tanaka S; Yamada Y; Baba S; Kinoshita H; Yamazaki K; Ikeda T; Minatoya K; Yutaka Y; Hamaji M; Ohsumi A; Nakajima D; Date H
Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36723127
[TBL] [Abstract][Full Text] [Related]
13. [Chronic Lung Allograft Dysfunction after Living-donor Lobar Lung Transplantation].
Sugimoto S; Tanaka S; Miyoshi K; Toyooka S
Kyobu Geka; 2022 Apr; 75(4):297-301. PubMed ID: 35342161
[TBL] [Abstract][Full Text] [Related]
14. Bronchial healing after living-donor lobar lung transplantation.
Toyooka S; Yamane M; Oto T; Sano Y; Okazaki M; Date H
Surg Today; 2009; 39(11):938-43. PubMed ID: 19882314
[TBL] [Abstract][Full Text] [Related]
15. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
Castro A; Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
HLA; 2017 Nov; 90(5):267-275. PubMed ID: 28776960
[TBL] [Abstract][Full Text] [Related]
16. Living-donor lobar lung transplantation.
Date H
J Heart Lung Transplant; 2024 Jan; 43(1):162-168. PubMed ID: 37704161
[TBL] [Abstract][Full Text] [Related]
17. Emphysematous changes and lower levels of plasma irisin are associated with bronchiolitis obliterans syndrome after bilateral living-donor lobar lung transplantation.
Shiotani T; Sugimoto S; Yamamoto H; Miyoshi K; Otani S; Suzawa K; Yamamoto H; Okazaki M; Yamane M; Toyooka S
Surg Today; 2022 Feb; 52(2):294-305. PubMed ID: 34251508
[TBL] [Abstract][Full Text] [Related]
18. Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection.
Chen F; Miyagawa-Hayashino A; Yurugi K; Chibana N; Yamada T; Sato M; Aoyama A; Takakura S; Bando T; Date H
Transpl Int; 2014 Feb; 27(2):e8-12. PubMed ID: 24164400
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
Lee H; Han E; Choi AR; Ban TH; Chung BH; Yang CW; Choi YJ; Oh EJ
PLoS One; 2018; 13(11):e0207434. PubMed ID: 30427941
[TBL] [Abstract][Full Text] [Related]
20. Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.
Reinsmoen NL; Lai CH; Mirocha J; Cao K; Ong G; Naim M; Wang Q; Haas M; Rafiei M; Czer L; Patel J; Kobashigawa J
Transplantation; 2014 Mar; 97(5):595-601. PubMed ID: 24162250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
